Replenish Nutrients Holding Corp. (CSE:ERTH)
Canada · Delayed Price · Currency is CAD 0.3000
-0.0100 (-3.23%)
Aug 28, 2026, 3:49 PM EST
CSE:ERTH Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6.33 | 6.81 | 6.9 | 13.92 | 17.27 | 12.3 | |
Revenue Growth | -3.38% | -1.23% | -50.43% | -19.41% | 40.41% | 2326.63% |
Operations & Maintenance | - | - | - | - | 0.2 | - |
Selling, General & Admin | 2.45 | 2.38 | 2.45 | 2.46 | 3.11 | 5.02 |
Depreciation & Amortization | 1.78 | 2.26 | 2.2 | 2.2 | 1.9 | 1.21 |
Provision for Bad Debts | 0.04 | 0.04 | 0.18 | -0.14 | -0.4 | 0.65 |
Other Operating Expenses | 6.72 | 6.62 | 6.26 | 12.56 | 14.92 | 9 |
Total Operating Expenses | 11.29 | 11.55 | 12.06 | 17.48 | 20.62 | 16.03 |
Operating Income | -4.95 | -4.73 | -5.16 | -3.56 | -3.35 | -3.73 |
Interest Expense | -1.23 | -0.95 | -0.2 | -0.21 | -0.17 | -0.12 |
Interest Income | - | - | - | 0.02 | 0.01 | 0 |
Net Interest Expense | -1.23 | -0.95 | -0.2 | -0.19 | -0.16 | -0.11 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0 | -0.01 | -0.04 | -0.02 |
Other Non-Operating Income (Expenses) | 0.19 | 0.09 | 0.12 | 0.17 | 0.24 | 0.11 |
EBT Excluding Unusual Items | -6.01 | -5.6 | -5.24 | -3.6 | -3.31 | -3.76 |
Total Merger & Restructuring Charges | - | - | - | - | -0.53 | -0.15 |
Impairment of Goodwill | - | - | - | - | -1.72 | - |
Gain (Loss) on Sale of Assets | - | - | -0.04 | 0 | -0.18 | - |
Asset Writedown | -3.04 | -3.04 | -3.18 | - | -1.31 | - |
Insurance Settlements | - | - | - | 0.4 | 0.04 | - |
Other Unusual Items | - | - | 3.1 | 2.67 | -0.72 | -0.73 |
Pretax Income | -9.52 | -8.64 | -5.36 | -0.52 | -7.73 | -4.63 |
Income Tax Expense | - | - | -1.09 | -0.61 | -0.65 | 0.07 |
Net Income | -9.52 | -8.64 | -4.27 | 0.08 | -7.08 | -4.7 |
Net Income to Common | -9.52 | -8.64 | -4.27 | 0.08 | -7.08 | -4.7 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 177 | 155 | 142 | 142 | 120 | 75 |
Shares Outstanding (Diluted) | 177 | 156 | 142 | 142 | 120 | 75 |
Shares Change | 32.21% | 10.01% | - | 18.14% | 60.98% | 59.89% |
EPS (Basic) | -0.05 | -0.06 | -0.03 | 0.00 | -0.06 | -0.06 |
EPS (Diluted) | -0.06 | -0.06 | -0.03 | 0.00 | -0.06 | -0.06 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.91 | -3.23 | -0.14 | -2.2 | -8.7 | -2.34 |
Free Cash Flow Per Share | -0.01 | -0.02 | -0.00 | -0.02 | -0.07 | -0.03 |
Profit Margin | -150.36% | -126.84% | -61.89% | 0.60% | -41.02% | -38.24% |
Free Cash Flow Margin | -30.22% | -47.43% | -2.00% | -15.81% | -50.38% | -19.03% |
EBITDA | -3.44 | -2.75 | -3.22 | -1.59 | -1.52 | -2.59 |
EBITDA Margin | -54.34% | -40.32% | -46.61% | -11.44% | -8.81% | -21.03% |
D&A For EBITDA | 1.51 | 1.99 | 1.95 | 1.97 | 1.83 | 1.15 |
EBIT | -4.95 | -4.73 | -5.16 | -3.56 | -3.35 | -3.73 |
EBIT Margin | -78.20% | -69.48% | -74.81% | -25.61% | -19.42% | -30.36% |